Vax-innate: Cancer vaccine reduces tumour growth

eAwaz Medicine

LA – An experimental cancer vaccine has proven to be significantly effective when tested on laboratory rats, according to a research team with the National Institutes of Health. The new drug, designed by Dr Robert Seder and his colleagues at the NIAID Vaccine Research Centre, successfully led to dramatic tumour regression in mice, offering hope that experts might be closing in on finding effective cancer treatment. The vaccine weakens cancerous cells and prevents suppression of T-cell action.